Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients.


Radiation Oncology Department, La Pitié-Salpêtrière Universitary Hospital, Paris, France. Electronic address: [Email]


The objective of the study was to evaluate the outcomes in terms of efficacy and safety of a large consecutive series of 362 patients with renal cell carcinoma (RCC) brain metastases treated using stereotactic radiosurgery (SRS) in the tyrosine kinase inhibitor (TKI) era.


Brain neoplasm metastases,Combined modality therapy,Kidney neoplasms,Radiosurgery,Systemic therapy and radiation therapy,